Welcome to siRNA transfection resource. In biomedical applications, this process of RNA interference has encouraged researchers to study ways in which this process can be utilized to shut down or effectively incapacitate a defective or non-wanted gene’s ability to replicate. These studies focus on conditions such as cancer and autoimmune diseases. Research is underway by academic institutions and pharmaceutical companies around the world to utilize the testing of RNAi-based functions and RNAi therapies to treat conditions such as viral infections and cancer. Small interfering RNA, more commonly known as, belong to a class of double-stranded RNA molecules, known as silencing RNA. Commonly studied and analyzed in the field of molecular biology, siRNA defines a mechanism of cellular replication (or inhibition) that has been greatly utilized in research of antiviral defense mechanisms.
Principles and Mechanisms of Mammalian Cell Transfection
siRNA is vastly utilized in molecular genetics as a research tool in RNAi technologies and studies. Techniques and reagents are utilized for laboratory experimental testing of novel RNAi therapeutics. Here you will find information about RNA Interference (RNAi) and small interferring RNA (siRNA), experimental transfection, siRNA transfection, pre-optimized and commercial siRNA services, stable transfection of shRNA-expressing plasmids, microRNA, in vivo delivery technologies, high-throughput RNAi, preclinical RNAi, commercial, and other topics. Several RNAi laboratories (such as ) provide a number of siRNA laboratory services and products in application research, as well as in the development of new treatments and therapeutic drugs, vectors, creation of stable RNAi cell lines, siRNA transfection reagents, and in vivo products for siRNA tissue targeted delivery (read more about commercially available in vivo ). When it comes to scientific research in biotechnology and pharmaceutical industries, the number of commercially available RNAi laboratory services around the world has expanded, increasing not only new discoveries in RNAi applications, but in research capable of targeting specific drugs and pharmaceuticals that may soon be utilized in clinical testing scenarios on humans. CRO Pre-clinical research services by Altogen Labs by Altogen Labs Quicksilver Scientific is a leading manufacturer of advanced nutritional systems with a focus on detoxification. At Quicksilver Scientific, we are passionate about health and well-being, and are committed to improving the lives of everyone we touch.
Founder and CEO,, is the driving force of Quicksilver Scientific. He is known worldwide for his research and development of industry-advanced mercury testing methods and health supplements that detoxify the human body of heavy metals and other toxins. Founder and CEO, Dr. Christopher Shade is the driving force of Quicksilver Scientific. He earned his B. S. And M.
Update Liposomes and Hairloss hairloss research org
Degrees in environmental and aqueous chemistry from Lehigh University and his Ph. D. From the University of Illinois, where he studied metal-ligand interactions in the environment and specialized in the environmental and analytical chemistries of mercury. During this time, Dr. Shade patented an analytical technology for and later founded Quicksilver Scientific as a way to commercialize this technology. This beneficial combination promotes healthy cellular function. Previous article in issue Next article in issue Keywords Antioxidants Activity Measurement Food Biological systems Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution. We introduce a simple and cost-effective technique for the efficient transient transfection of suspension cells through the coating of cell culture plates with chicken egg white. The method is characterized by minimal toxicity and correct gene expression. Although established for the mast cell line C7 and the myeloid cell line HL-65 the technique is likely to be used for other suspension cell lines as well. Our improved protocol demonstrates that the overcoming of the non-adherent character of suspension cells substantially supports transfection efficiency, and that this can be achieved by a simple chicken egg white-based system. However, not all transfection methods can be applied to all types of cells, and there is a wide variation with respect to the achieved cell viability and the expression level of the gene of interest. The determination of the most appropriate transfection technique depends on several factors, such as the cell type or the adherence ability of the cells.
Suspension cell lines have traditionally proven to be very difficult to transfect. Here we present an efficient transfection method for suspension cell lines (please see our protocol for details). In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it.